Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AngiographiC Evaluation of the Everolimus-Eluting Stent in Chronic Total Occlusions - the ACE-CTO Study

NCT01012869 is registered in ClinicalTrials.gov with North Texas Veterans Healthcare System as lead sponsor.

NCT NCT01012869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01012869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AngiographiC Evaluation of the Everolimus-Eluting Stent in Chronic Total Occlusions - the ACE-CTO Study
Lead sponsor
North Texas Veterans Healthcare System
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2009
Completion date
June 30, 2013
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary occlusions